Encephalomyocarditis Virus

Encephalomyocarditis (EMC) is a viral disease of pigs caused by the Encephalomyocarditis virus (EMCV), a member of the genus Cardiovirus within the family Picornaviridae. This disease is characterized primarily by acute myocarditis (inflammation of the heart muscle), sudden death, and reproductive failure in pigs, though neurological signs can also occur as the name implies. EMCV has an extremely broad host range including virtually all mammals, birds, and some reptiles, but clinical disease occurs most commonly and severely in domestic pigs and certain zoo animals. Rodents serve as the primary reservoir hosts and are responsible for introducing and maintaining infection in pig facilities.

Encephalomyocarditis affects pigs of all breeds and ages, but clinical disease is most severe in young piglets and breeding sows. In piglets, especially those under three weeks of age, infection typically results in acute myocarditis with sudden death, often without preceding clinical signs. Mortality rates in young pigs during outbreaks can exceed 50%, causing devastating losses in farrowing operations. Adult pigs generally experience subclinical infection or mild illness, though pregnant sows may suffer reproductive losses including embryonic death, mummified fetuses, and stillbirths. The disease has worldwide distribution, with outbreaks reported from swine-producing regions across North America, South America, Europe, Asia, and Australia.

The economic impact of EMCV infection in swine operations varies considerably depending on the population affected and outbreak severity. In naive herds experiencing first-time exposure, losses from piglet mortality and reproductive failure can be substantial. The sudden death of large numbers of piglets with minimal preceding clinical signs creates both direct financial losses and psychological impact on farm personnel. Reproductive losses in breeding herds compound the economic damage through decreased piglet production over extended periods. Survivors of myocarditis may have permanently damaged hearts with reduced exercise tolerance and increased susceptibility to stress-related death during subsequent handling or transport. However, EMCV typically does not have trade implications like some other viral diseases, as it is not generally considered a notifiable disease.

Treatment of EMCV infection is limited to supportive care, as no specific antiviral therapy exists for this picornavirus infection. Prevention focuses primarily on rodent control, as eliminating the rodent reservoir is the most effective means of preventing viral introduction and spread within pig facilities. Vaccination is available in some regions and can be effective at reducing clinical disease and reproductive losses in endemic situations. Early recognition of the disease pattern—particularly sudden death in young piglets associated with rodent problems—enables prompt implementation of control measures to limit ongoing losses.

Encephalomyocarditis virus (EMCV) is a small, non-enveloped, single-stranded RNA virus belonging to the genus Cardiovirus within the family Picornaviridae. This virus family also includes important human pathogens such as poliovirus, hepatitis A virus, and rhinoviruses. EMCV is notable for its exceptionally broad host range, with susceptibility documented in over 30 mammalian species, numerous bird species, and even some reptiles. Multiple strains of EMCV exist with varying levels of virulence, tissue tropism, and host adaptation. The virus is relatively stable in the environment and can survive for extended periods in contaminated water, feed, and organic material.

Genetic predisposition to EMCV susceptibility does not vary significantly among domestic pig breeds, and all breeds are considered equally at risk for infection. However, age is a critical determinant of disease severity, with young piglets being dramatically more susceptible to fatal myocarditis than older pigs. This age-related susceptibility likely reflects differences in cardiac development and immune maturation rather than genetic resistance factors. Research has not identified breed-specific genetic markers for EMCV resistance or tolerance, and prevention strategies focus on environmental control rather than genetic selection.

Environmental factors play a dominant role in EMCV epidemiology, with rodent populations serving as the critical reservoir and transmission source. Wild rodents, particularly rats and mice, maintain the virus in nature and can harbor high levels of EMCV without showing clinical disease. Infected rodents shed virus in their urine, feces, and other secretions, contaminating the environment, feed, water, and bedding materials in pig facilities. Heavy rodent infestations are strongly associated with EMCV outbreaks in swine, and facilities with poor rodent control face significantly higher disease risk. Seasonal patterns often reflect rodent behavior, with increased risk during cold months when rodents seek shelter in buildings.

Risk factors for EMCV infection and clinical disease include proximity to rodent populations, inadequate rodent control programs, feed storage conditions that attract rodents, building construction that allows rodent entry, and presence of young piglets or pregnant sows. Facilities with outdoor access or open-sided buildings face higher exposure risk. Feed ingredients, particularly grains, may be contaminated with EMCV at the source or during storage. Water sources accessible to rodents can serve as transmission routes. Stressors such as weaning, transport, or concurrent disease may increase susceptibility to clinical illness following exposure.

The pathophysiology of EMCV infection involves viral entry through the oral or possibly respiratory route, followed by initial replication in the gastrointestinal tract and subsequent viremia. The virus has particular tropism for cardiac myocytes (heart muscle cells), where replication causes direct cellular damage and triggers inflammatory responses that compound tissue injury. In severe cases, extensive myocardial necrosis leads to acute heart failure and death. The developing hearts of young piglets appear particularly vulnerable to viral damage, explaining the age-related difference in disease severity. Neurological manifestations occur when virus invades the central nervous system, though cardiac disease typically predominates in pigs. In pregnant sows, transplacental infection results in fetal death at various stages of development.

Early warning signs of encephalomyocarditis virus infection may be absent or extremely subtle, particularly in the acute cardiac form that most commonly affects young piglets. In many outbreaks, the first indication of disease is the discovery of dead piglets that appeared healthy the previous day. Some affected animals may show transient lethargy, reduced nursing behavior, or mild respiratory distress in the hours before death, but these signs are often overlooked or attributed to other causes. In breeding herds, early indicators might include increased embryonic losses or higher than normal returns to estrus that precede recognition of the myocardial disease pattern in piglets.

The classic presentation of acute EMCV myocarditis in piglets involves sudden death without obvious preceding clinical signs. Affected piglets may be found dead in the farrowing crate with milk still in their stomachs, indicating that death occurred very rapidly after recent nursing. When clinical signs are observed before death, they typically include acute respiratory distress, cyanosis (bluish discoloration of extremities), weakness, and collapse. Affected piglets may show rapid, labored breathing and appear cold and weak. Death usually occurs within hours of the onset of visible signs. Mortality during outbreaks primarily affects piglets under three weeks of age, with devastating losses possible in individual litters and across the farrowing population.

Neurological manifestations of EMCV infection are less common than cardiac disease in pigs but can occur, particularly with certain viral strains. Affected animals may show tremors, incoordination, posterior paresis (weakness of the hind legs), circling, and convulsions. Neurological signs may occur independently or in conjunction with cardiac disease. Adult pigs are more likely than piglets to survive long enough to display neurological signs, as the rapidly fatal myocarditis in young animals often precludes the development of obvious encephalitic manifestations. Complete or partial paralysis may develop in severe cases.

Reproductive manifestations in breeding herds occur when pregnant sows become infected with EMCV. The consequences depend on the stage of gestation at which infection occurs. Early pregnancy infection results in embryonic death with increased returns to estrus or pseudopregnancy. Mid-gestation infection causes fetal death with mummification, showing the characteristic range of fetal sizes reflecting the timing of infection. Late pregnancy infection may result in stillbirths, weak-born pigs, or apparently normal piglets that develop myocarditis postnatally. Sows themselves typically show minimal clinical signs despite active infection, making diagnosis challenging without investigation of reproductive losses.

Symptom progression in EMCV cardiac disease is extremely rapid, often measured in hours rather than days. Piglets showing early signs of respiratory distress or weakness typically deteriorate quickly to recumbency and death. Survivors of acute infection may show chronic effects including exercise intolerance, poor growth, and increased susceptibility to stress-related death. In neurological cases, progression may be somewhat slower, with signs developing over 1 to 3 days, though outcomes remain generally poor. Adult pigs with subclinical infection show no obvious signs but develop antibodies indicating exposure.

Emergency symptoms requiring immediate attention include sudden death of multiple piglets within a short time period, particularly in the absence of other obvious disease, and especially when associated with evidence of rodent infestation. Discovery of dead piglets that appeared healthy hours earlier, respiratory distress with cyanosis in young pigs, and abortion or increased reproductive losses in sows should all prompt investigation for EMCV along with other potential causes. While EMCV is not typically a regulatory emergency like some viral diseases, rapid diagnosis enables implementation of control measures to limit further losses.

Clinical diagnosis of encephalomyocarditis virus infection relies on recognition of the characteristic disease pattern—sudden death in young piglets with myocarditis at necropsy, often associated with rodent problems in the facility. The age group affected (primarily piglets under three weeks), the acute nature of deaths, and the cardiac pathology distinguish EMCV from many other causes of piglet mortality. History of rodent infestation, recently introduced rodent control measures that may have increased rodent contact with pigs, or clustering of deaths in certain areas of the facility all support suspicion of EMCV. Clinical examination of affected or at-risk piglets may reveal tachycardia, weak pulses, respiratory distress, or cyanosis.

Laboratory diagnosis of EMCV employs several methods for virus detection and serological confirmation. Virus isolation from heart tissue, brain, spleen, or other organs can be performed in cell culture, with characteristic cytopathic effects confirming infection. Polymerase chain reaction (PCR) provides rapid and sensitive detection of viral RNA in clinical samples and is increasingly the primary diagnostic method. Immunohistochemistry on fixed tissue sections can demonstrate viral antigen in myocardial lesions, providing direct evidence of EMCV involvement. Serological testing using ELISA or virus neutralization assays detects antibodies in recovered animals and can be used for herd surveillance, though acute deaths may occur before antibody development.

Postmortem examination provides critical diagnostic information in EMCV cases. Gross findings may include pale, mottled heart muscle with areas of hemorrhage or necrosis, pulmonary edema and congestion, and variable changes in other organs. The heart lesions may be subtle grossly despite severe microscopic changes. Histopathological examination reveals myocardial necrosis with lymphocytic infiltration characteristic of viral myocarditis. Mineralization of damaged cardiac tissue may be visible in more chronic cases. Brain lesions including neuronal degeneration and perivascular cuffing may be present in cases with neurological involvement.

Differential diagnosis for EMCV in piglet mortality includes other causes of sudden death such as iron deficiency, hypoglycemia, crushing by the sow, and other infections. Bacterial septicemia from Streptococcus suis, Escherichia coli, or other pathogens can cause rapid death in young pigs. Porcine reproductive and respiratory syndrome (PRRS), pseudorabies, and other viral infections may cause piglet mortality with different patterns. For reproductive losses, numerous infectious and non-infectious causes must be considered including parvovirus, leptospirosis, and PRRS. The combination of piglet myocarditis, reproductive losses, and rodent association helps distinguish EMCV from these alternatives.

There is no specific antiviral treatment for encephalomyocarditis virus infection in pigs. The picornavirus family, while extensively studied in human medicine, has not yielded veterinary-approved antivirals for EMCV control in swine. Experimental antiviral compounds have shown activity against EMCV in laboratory settings, but none are available or practical for field use. The extremely rapid progression of acute myocarditis in young piglets—often fatal within hours of clinical signs—further limits treatment opportunities. Management of EMCV outbreaks therefore focuses on supportive care, prevention of further transmission, and long-term control through rodent management.

Emergency management of EMCV outbreaks emphasizes immediate environmental intervention to reduce ongoing exposure. Aggressive rodent control measures should be implemented promptly, though care must be taken to avoid creating additional contamination as dying or disoriented rodents may increase contact with pigs. Dead rodents should be removed promptly and disposed of safely. Feed bins, water sources, and bedding storage areas should be inspected for rodent contamination and cleaned thoroughly. Movement of potentially contaminated materials between barns should be restricted. In some situations, temporary removal of susceptible animals (young piglets, pregnant sows) from heavily contaminated areas may be considered.

Supportive care for clinically affected piglets is generally unsuccessful due to the rapid progression of cardiac disease, but may be attempted for animals with mild or early signs. Minimizing stress and handling reduces cardiac workload in animals with compromised heart function. Maintaining appropriate environmental temperature supports struggling piglets. Ensuring adequate nutrition through assisted nursing or milk replacement may help maintain strength. Anti-inflammatory medications have been suggested but lack proven efficacy and do not address the underlying viral damage. Realistically, piglets showing clinical signs of EMCV myocarditis have poor prognosis, and humane euthanasia may be appropriate for severely affected animals.

Herd-level management during EMCV outbreaks includes both immediate control measures and longer-term prevention strategies. Vaccination of breeding sows before or during outbreaks can reduce reproductive losses and provide passive protection to piglets through colostral antibodies. Multiple vaccine products are available in some regions, though availability varies by country. Sow vaccination typically involves a primary series followed by booster doses before subsequent farrowings. Piglet vaccination is less commonly practiced due to the early age at which disease occurs and potential interference from maternal antibodies.

Treatment decisions in EMCV situations balance individual animal care against herd-level interventions. For individual clinically affected piglets, treatment options are limited and prognosis is poor. Resources are generally better directed toward environmental intervention and prevention of additional cases. Economic analysis should consider the costs of intensive rodent control, potential vaccination programs, and ongoing losses during the outbreak period. The value of eliminating rodent reservoirs extends beyond EMCV to other rodent-borne diseases and general facility hygiene.

Long-term control strategy following EMCV outbreaks centers on sustained rodent control as the cornerstone of prevention. Integrated pest management programs combining physical exclusion, elimination of food and harborage sources, and targeted rodenticide use provide the most effective long-term control. Building maintenance to eliminate rodent entry points and nesting sites addresses the underlying vulnerability. Regular monitoring for rodent activity enables early intervention before populations reach outbreak-promoting levels. In facilities with endemic EMCV pressure, ongoing sow vaccination may be incorporated into standard herd health protocols.

Recovery from acute encephalomyocarditis virus infection is uncommon in young piglets that develop clinical myocarditis, as the disease typically progresses to death within hours. Piglets that survive acute infection may have permanently damaged hearts with areas of scarring and fibrosis replacing normal cardiac muscle. These survivors often show poor growth performance, exercise intolerance, and increased susceptibility to stress-related sudden death. During handling, transport, or other stressful events, pigs with EMCV-damaged hearts may die unexpectedly. For these reasons, apparent recovery from clinical disease does not indicate return to normal cardiac function.

Recovery at the herd level following EMCV outbreaks depends on successful implementation of rodent control and, where applicable, vaccination programs. Mortality rates typically decline as the most susceptible animals are lost and rodent populations are reduced. Development of herd immunity through natural exposure or vaccination reduces the impact of ongoing viral circulation. However, complete elimination of EMCV from a facility requires elimination of the rodent reservoir, which can be challenging in older facilities with numerous potential entry points and harborage sites. Persistent rodent problems lead to ongoing endemic disease pressure.

Prognosis for affected individuals is generally poor for piglets showing clinical signs of myocarditis, guarded for animals with subclinical infection that may have occult cardiac damage, and fair for adult pigs that typically experience only subclinical infection. Reproductive prognosis for affected sows is generally good following resolution of the acute infection, though repeat breeding may be necessary if pregnancy was lost. The prognosis for the herd depends on the effectiveness of control measures; facilities that achieve sustained rodent control can expect minimal ongoing losses, while those with persistent rodent problems will continue to experience endemic disease.

Return to production for surviving piglets requires recognition that cardiac damage may be permanent. Affected pigs may not reach normal market weights and may have elevated risk of death during transport to slaughter. Management modifications such as reduced handling stress, avoiding extreme temperatures, and careful transport protocols may reduce losses in recovered animals. For breeding stock purposes, survivors of clinical EMCV infection are generally not suitable candidates due to potential cardiac compromise and stress intolerance. Monitoring of the herd over time with attention to mortality patterns helps assess the success of control measures and guide ongoing management decisions.

Vaccination against encephalomyocarditis virus is available in some regions and provides effective protection against clinical disease and reproductive losses. Killed (inactivated) virus vaccines are most commonly used, with primary vaccination of breeding gilts and sows followed by booster doses to maintain immunity. Vaccination of pregnant sows provides passive protection to piglets through colostral antibodies during the critical early weeks of life when they are most susceptible to fatal myocarditis. Vaccine effectiveness depends on proper timing, storage, and administration. Multiple commercial products exist, though availability varies by country and market demand.

Rodent control represents the cornerstone of EMCV prevention and must be addressed regardless of vaccination status. Comprehensive integrated pest management programs combine multiple strategies for maximum effectiveness. Physical exclusion through building maintenance, sealing entry points, and installation of door sweeps and screens prevents rodent entry. Elimination of food sources includes proper feed storage in rodent-proof containers, prompt cleanup of spilled feed, and removal of attractants around facilities. Reduction of harborage sites through vegetation management, removal of debris, and organization of storage areas reduces rodent populations. Targeted rodenticide programs using appropriate bait stations provide ongoing population suppression.

Nutritional management does not directly prevent EMCV infection but supports overall immune function and animal resilience. Adequate colostrum intake by neonatal piglets provides maternal antibodies when sows have been vaccinated or naturally exposed. Proper nutrition of sows during gestation and lactation optimizes colostrum quality and quantity. Maintaining appropriate nutritional status in all animals supports immune responses to vaccination and reduces susceptibility to clinical disease following exposure. Stress reduction through proper nutrition and environmental management supports overall health.

Management practices for EMCV prevention integrate rodent control with facility hygiene and herd health programs. Regular facility inspection identifies rodent entry points, evidence of activity, and conditions favoring infestation. Feed delivery and storage protocols minimize contamination opportunities. Water sources should be protected from rodent access. All-in-all-out production with thorough cleaning between groups removes potential environmental contamination. Personnel should be trained to recognize and report rodent activity. Dead rodents should be removed promptly using appropriate precautions.

Surveillance and monitoring programs help detect EMCV activity and guide control measures. Monitoring of piglet mortality patterns, particularly sudden death in young animals, enables early recognition of potential EMCV involvement. Routine diagnostic investigation of unexplained piglet deaths should include consideration of EMCV testing. Rodent monitoring using tracking boards, bait stations, or visual observation provides information on population levels and activity patterns. Serological surveillance of sow populations can indicate exposure levels and vaccination effectiveness. Regular evaluation of control program effectiveness guides adjustments to prevention strategies.

Daily management and monitoring for EMCV prevention focuses on vigilance for both disease signs and rodent activity. Daily health checks in farrowing areas should note any unexplained piglet deaths, particularly those occurring in apparently healthy litters. Attention to piglet vitality, nursing behavior, and overall appearance helps identify early signs of illness. Concurrent monitoring for rodent evidence including droppings, gnaw marks, tracks, and sightings enables prompt response to increased rodent activity. Recording of observations supports identification of patterns and evaluation of control measures over time.

Housing and environmental management play critical roles in EMCV prevention by reducing rodent access and populations. Building construction and maintenance should prioritize rodent exclusion through proper sealing of gaps, installation of screens and door sweeps, and repair of damage that creates entry points. Facility layout should facilitate cleaning and inspection, avoiding areas where rodent activity could go unnoticed. Exterior areas surrounding buildings should be maintained to reduce harborage—vegetation trimmed back from walls, debris removed, and materials stored away from building perimeters. Proper drainage prevents water accumulation that attracts rodents.

Herd health programs addressing EMCV integrate prevention measures with overall reproductive and piglet health management. Vaccination protocols for sows should be developed with veterinary guidance based on disease history and local risk factors. Timing of vaccination relative to farrowing optimizes colostral antibody transfer to piglets. Integration of EMCV prevention with other aspects of sow herd health—nutrition, parasite control, management of other reproductive diseases—supports overall reproductive success. Regular veterinary review of mortality patterns and diagnostic findings helps identify EMCV involvement and assess prevention effectiveness.

Record keeping systems should capture information relevant to EMCV monitoring and control. Piglet mortality records noting age, litter, location, and circumstances of death enable pattern recognition. Rodent monitoring records document activity levels, bait consumption, and control measures implemented. Vaccination records confirm protocol compliance and scheduling of boosters. Diagnostic test results document disease confirmation and provide baseline for comparison. Production records including reproductive performance and pre-weaning mortality provide outcome measures for evaluating control program success.

Economic considerations in EMCV management include both direct prevention costs and potential losses from inadequate control. Rodent control program costs include personnel time, materials (bait stations, rodenticides), building maintenance, and professional pest management services where utilized. Vaccination costs include vaccine purchase, labor for administration, and veterinary oversight. These prevention costs should be weighed against potential losses from EMCV outbreaks—piglet mortality, reproductive losses, reduced growth performance in survivors, and potential for increased losses from other rodent-associated problems. Effective prevention programs typically provide positive return on investment in facilities with EMCV risk.

All domestic pig breeds are susceptible to encephalomyocarditis virus infection without significant genetic variation in resistance. Commercial breeds including Large White, Landrace, Duroc, Pietrain, and Hampshire all experience similar disease patterns when exposed to EMCV. Heritage breeds, indigenous breeds from various global regions, and miniature pig varieties are equally susceptible. The primary risk factor for severe clinical disease is age rather than breed, with young piglets under three weeks of age being dramatically more susceptible to fatal myocarditis than older pigs of any breed. Research has not identified breed-specific genetic markers for EMCV resistance.

Production type influences EMCV risk primarily through facility characteristics and management practices rather than inherent breed differences. Large commercial farrowing operations face significant risk due to the concentration of susceptible young piglets, though they may have more resources for rodent control infrastructure. Older facilities with deteriorated construction present greater challenges for rodent exclusion. Outdoor or hoop-based production systems may have different rodent pressure patterns than fully enclosed buildings. Operations with on-farm feed processing and storage may face higher rodent attraction. Small-scale and backyard operations may have limited rodent control capacity but also smaller populations at risk.

Genetic selection for EMCV resistance is not currently a focus of pig breeding programs due to the dominance of management factors in disease prevention. The age-related susceptibility reflects physiological factors in cardiac and immune development rather than variation that could be selected for genetically. Research has explored the basis for host species differences in EMCV susceptibility, but application to within-species genetic selection in pigs has not emerged. Prevention strategies continue to rely on environmental control through rodent management, vaccination where available, and general herd health practices rather than genetic improvement for disease resistance.

Porcine reproductive and respiratory syndrome (PRRS) is a common differential diagnosis for reproductive losses associated with EMCV. Both diseases can cause abortion, mummification, stillbirths, and weak-born piglets in breeding herds. PRRS also causes respiratory disease and mortality in growing pigs, distinguishing it from the primarily cardiac manifestations of EMCV. Co-infection with both viruses can occur. Porcine parvovirus is another cause of reproductive failure with similar manifestations but without the piglet myocarditis component. Diagnostic testing for these and other reproductive pathogens is often performed concurrently when investigating sow herd losses.

Other causes of sudden death in young piglets must be differentiated from EMCV myocarditis. Bacterial septicemia from Streptococcus suis, Escherichia coli, Klebsiella species, or other pathogens can cause rapid death with minimal preceding signs. Clostridial diseases, though less common in well-managed herds, can cause sudden death. Non-infectious causes including crushing by the sow, hypothermia, hypoglycemia, and iron deficiency can cause piglet mortality. The characteristic cardiac lesions at necropsy distinguish EMCV from most of these alternatives, though laboratory confirmation remains important.

Complications and sequelae of EMCV infection include chronic cardiac insufficiency in survivors, increased susceptibility to stress-related death, and potential for endemic circulation in facilities with persistent rodent problems. Pigs surviving myocarditis may have permanently reduced cardiac function with implications for growth performance and tolerance of handling and transport stress. Secondary bacterial infections may complicate cases where animals survive the initial viral damage. The economic sequelae of EMCV outbreaks extend beyond immediate mortality to include ongoing production impacts and the costs of sustained prevention programs necessary to prevent recurrence.